Letter to the EditorFibroblast Growth Factor 21 Is Elevated in HIV and Associated With Interleukin-6Eckard, Allison Ross MDa; Hughes, Heather Y. MDa,b; Hagood, Nancy L. BSa; O'Riordan, Mary A. PhDc,d; Labbato, Danielle RNc; Kosco, Julia C. MPHc; Scott, Sarah E. MDc; McComsey, Grace A. MDc,dAuthor Information aDivision of Infectious Diseases, Department of Pediatrics, Medical University of South Carolina, Charleston, SC bDivision of Infectious Diseases, Department of Pediatrics, Ralph H. Johnson VA Medical Center, Charleston, SC cDivision of Infectious Diseases, Department of Pediatrics, University Hospitals Cleveland Medical Center, Clinical Research Center, Cleveland, OH dDivision of Infectious Diseases, Department of Pediatrics, Case Western Reserve University School of Medicine, Cleveland, OH Supported by the National Institutes of Health (R21DK118757 to G.A.M.; R01DK121619 to G.A.M. and A.R.E.), Case Western Reserve University's Center for AIDS Research (P30 AI36219), and University Hospitals Cleveland Medical Center (UHCMC) and the Clinical and Translational Science Collaborative of Cleveland (UL1TR000439) from the National Center for Advancing Translational Sciences (NCATS) component of the National Institutes of Health and NIH roadmap for Medical Research. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of UHCMC or the NIH. A.R.E. has received research funding from Bristol-Myers Squibb, Cubist Pharmaceuticals, and GlaxoSmithKline and has served as an advisor and speaker for Gilead Sciences and Theratechnologies, Inc. G.A.M. serves as a consultant for Bristol-Myers Squibb, ViiV/GlaxoSmithKline, Gilead, Pfizer, and ICON and has received grant funding from Bristol-Myers Squibb, ViiV/GlaxoSmithKline, Merck, AstraZeneca, and Gilead. The remaining authors have no conflicts of interest to disclose. Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Web site (www.jaids.com). JAIDS Journal of Acquired Immune Deficiency Syndromes: April 15, 2020 - Volume 83 - Issue 5 - p e30-e33 doi: 10.1097/QAI.0000000000002285 Buy SDC Metrics Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.